Chronic Pain Clinical Trial
Official title:
Observation et Analyse Des Effets de la Stimulation transcrânienne à Courant Continu en Milieu Clinique Pour Soulager la Douleur Chronique Chez Les Travailleurs Vieillissants
Chronic pain is one of the main factors influencing workers' retention at work. Considering that the prevalence of suffering from chronic pain increases with age, older workers are most likely to be absent from work because of their pain. Transcranial direct current stimulation (tDCS) is a treatment option to reduce chronic pain. This study aims to document the effect of tDCS on pain and work retention in older workers and to compare the traditional tDCS protocol (5 sessions) with an enhanced protocol (11 sessions).
Status | Recruiting |
Enrollment | 24 |
Est. completion date | May 30, 2024 |
Est. primary completion date | April 30, 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 56 Years and older |
Eligibility | Inclusion Criteria: - To be more than 55 years old - To have chronic pain - To have employment relationship - To have pain that interferes with work tasks Exclusion Criteria: - tDCS contraindications (epilepsy, metallic implant in the head, pacemaker, cochlear implant) |
Country | Name | City | State |
---|---|---|---|
Canada | Clinique régionale de la gestion de la douleur - CISSSAT | Rouyn-Noranda | Quebec |
Canada | Centre de Recherche sur le Vieillissement | Sherbrooke | Quebec |
Lead Sponsor | Collaborator |
---|---|
Université de Sherbrooke | CISSS Abitibi-Témiscamingue |
Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Pain intensity | 0-10 Numerical rating scale | Before tDCS | |
Primary | Pain intensity | 0-10 Numerical rating scale | 1 week | |
Primary | Pain intensity | 0-10 Numerical rating scale | 4 weeks | |
Primary | Pain intensity | 0-10 Numerical rating scale | 4 weeks after the last tDCS session | |
Primary | Disability | Pain Disability Index | Before tDCS | |
Primary | Disability | Pain Disability Index | 1 week | |
Primary | Disability | Pain Disability Index | 4 weeks | |
Primary | Disability | Pain Disability Index | 4 weeks after the last tDCS session | |
Primary | Work role functioning | Work Role Functioning Questionnaire | Before tDCS | |
Primary | Work role functioning | Work Role Functioning Questionnaire | 1 week | |
Primary | Work role functioning | Work Role Functioning Questionnaire | 4 weeks | |
Primary | Work role functioning | Work Role Functioning Questionnaire | 4 weeks after the last tDCS session | |
Primary | Physical Functioning | Brief Pain Inventory | Before tDCS | |
Primary | Physical Functioning | Brief Pain Inventory | 1 week | |
Primary | Physical Functioning | Brief Pain Inventory | 4 weeks | |
Primary | Physical Functioning | Brief Pain Inventory | 4 weeks after the last tDCS session | |
Primary | Anxiety | Beck anxiety inventory | Before tDCS | |
Primary | Anxiety | Beck anxiety inventory | 1 week | |
Primary | Anxiety | Beck anxiety inventory | 4 weeks | |
Primary | Anxiety | Beck anxiety inventory | 4 weeks after the last tDCS session | |
Primary | Depression | Beck depression inventory | Before tDCS | |
Primary | Depression | Beck depression inventory | 1 week | |
Primary | Depression | Beck depression inventory | 4 weeks | |
Primary | Depression | Beck depression inventory | 4 weeks after the last tDCS session | |
Primary | Impression of change | Patient Global impression of change | 1 week | |
Primary | Impression of change | Patient Global impression of change | 4 weeks | |
Primary | Impression of change | Patient Global impression of change | 4 weeks after the last tDCS session | |
Primary | Central sensitization | central sensitization inventory | Before tDCS | |
Primary | Central sensitization | central sensitization inventory | 1 week | |
Primary | Central sensitization | central sensitization inventory | 4 weeks | |
Primary | Central sensitization | central sensitization inventory | 4 weeks after the last tDCS session | |
Secondary | Recruitment | Feasibility of the study | through study completion, about 2 years | |
Secondary | Security | Feasibility of the study | through study completion, about 2 years | |
Secondary | Intervention | Feasibility of the study | through study completion, about 2 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|